| EPIC | OXB |
| Sector | Pharma and Biotech |
| ISIN | GB00BDFBVT43 |
| Market Sector | MAIN |
| Market Segment | SSMM |
| Main Indices | techMARK, FTSE 250, FTSE 350, FTSE All-Share, FTSE techMARK Focus |
| Country of register | Great Britain |
| Currency | British Pound |
| Market Cap | £684.30m |
| NMS | 2,000 |
| Shares in issue | 120.90m |
| Date Listed | 17-Apr-2001 |
| Currency | UK Pounds |
| Share Price | 566.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 913.00p |
| 52 Week Low | 277.00p |
| Volume | 0 |
| Shares Issued | 120.90m |
| Market Cap | £684.30m |
| Beta | 0.03 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| No dividends found |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research